MARIO RIVAS - 01 Jan 2023 Form 4 Insider Report for Transphorm, Inc. (TGAN)

Role
Chief Executive Officer, Director
Signature
/s/ Cameron McAulay, Attorney-in-Fact
Issuer symbol
TGAN
Transactions as of
01 Jan 2023
Transactions value $
-$68,180
Form type
4
Filing time
04 Jan 2023, 15:08:14 UTC
Previous filing
21 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TGAN Common Stock Award $0 +16,544 +14% $0 134,746 01 Jan 2023 Direct F1
transaction TGAN Common Stock Tax liability -$68,179 -12,533 -9.3% $5.44 122,213 01 Jan 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each share is represented by a Restricted Stock Unit ("RSU"). 100% of the RSUs will vest on January 1, 2024, subject to the Reporting Person's continued status as a Service Provider to the Issuer through that vesting date.
F2 The reported shares were withheld to cover the Reporting Person's tax liability in connection with the vesting of RSUs.